Summary Synthesis of pulmonary surfactant (PS) is necessary for normal functioning of the lungs and its production is indicative of normal differentiated lung. The human alveolar carcinoma, A549, has been found to synthesis and secrete PS in vitro. The purpose of this study was to optimise the culture conditions for PS synthesis by A549 as well as to determine the potential role of foetal lung fibroblasts in the induction of PS by glucocorticoids. A549 cells growing in filter wells produced higher levels of PS in response to steroid, a 5-fold increase on the filter well compared to only a 1.5-fold increase when the cells were cultured on a conventional plastic substrate. A549 cells grown in filter wells responded to coculture with fibroblasts whether in direct contact or separated co-culture. A 20-fold increase in PS over control values was observed in separated steroid-treated co-cultures, suggesting the presence of a diffusible factor. A partially purified factor was isolated from fibroblast conditioned medium which was capable of inducing differentiation and other phenotypic changes in A549, namely induction of PS, reduction of plasminogen activator activity and reduction in the in vivo growth of A549 xenografts in nude mice. These results suggest that, under the correct conditions, A549 cells, although transformed, still retain the capacity to respond to differentiation-inducing signals from normal fibroblasts.
As with many developing organ systems, organogenesis in embryonic lung is strongly dependent on mutual interactions between the epithelium and the mesenchyme (Taderera, 1967; Wessels, 1977; Smith & Fletcher, 1979) . While in some cases the inductive capacity of the mesoderm may be constitutive, in prostate and in lung at least part of the inductive capacity of the mesoderm is induced by the systemic action of steroid hormones Neubauer et al., 1983; Post et al., 1984) . In the perinatal maturation of the lung, glucocorticoids do not act directly on the type II cells of the alveolar epithelium, but indirectly via the lung mesenchyme (Post et al., 1984) . The production and presence of pulmonary surfactant (PS), a phospholipid-rich material which reduces surface tension thereby preventing alveolar collapse during the expiratory phase (Goerke, 1974) , is a major characteristic of lung maturity and the principal differentiated function of type II pneumocytes in the alveoli. Although PS production can be induced by glucocorticoids directly (McLean et al., 1986) , an indirect action, mediated by lung fibroblasts, has been shown to be the major perinatal inductive route (Post et al., 1984) . Binding of the glucocorticoid to fibroblastic receptors induces the release of a factor, fibroblast pneumocyte factor (FPF), which is the major inducer of synthesis of PS by type II cells.
There is evidence for both contact mediated and paracrine control of differentiation, induced by cell-cell interaction. While cell-cell contact or cell-matrix contact appears to be important in differentiation of the enterocyte (Kedinger et al., 1987 ) the effects seen in skin (Bohnert et al., 1986) , lung (Smith, 1979; Post et al., 1984) and some aspects of the prostatic response (Djakiew et al., 1990) are mediated by soluble factors.
Although the role of heterologous cell interaction in adult tissues is less clearly established, adult urinary bladder epithelium undergoes prostatic differentiation in response to urogenital sinus mesenchyme , and in skin an epidermal-dermal interaction is required for complete keratinisation and cross-linked envelope formation (Bohnert et al., 1986) . While a major breakdown of this type of interaction would be expected in tumours, there is evidence of some continuing interaction affecting both growth and differentiation. Fibroblasts co-cultured with tumour cells have been found to cause distinct degenerative changes in KB (HeLa contaminated: ATCC Catalogue, Rockville, MD) carcinoma cells (Imanishi et al., 1983) as well as growth inhibition and differentiation in a human salivary carcinoma (Shirasuna et al., 1988) . Normal skin stroma can induce basal cell carcinomas to express keratinisation (Boukamp et al., 1985) , and in vitro studies with NBT-II rat bladder carcinoma cells in culture demonstrated that diffusible factors produced by foetal urogenital sinus could influence the phenotype of the carcinoma cells, characterised by an inhibition of cell proliferation, a stimulation of protein secretion and an alteration in cell morphology (Rowley & Tindall, 1987) . It has also been shown in embryo implantation studies that interaction with the correct temporal phase at the correct site can inhibit the tumorigenic potential of melanoma and neuroblastoma (Podesta et al., 1984) .
The present report describes the role of fibroblasts in the glucocorticoid-induced differentiation of the alveolar carcinoma cell line, A549 (Giard et al., 1972) . It has been reported previously that this cell line is a good potential model for the study of alveolar maturation (Smith, 1977) 
Cells and culture
The human alveolar lung carcinoma cell line, A549, was obtained from the American Type Culture Collection (CCL 185, ATCC, Rockville, MD). MOG-L-DAN (laboratory identifiers, e.g. MOG, Medical Oncology Glasgow, will only be used on first mention of a cell line), was derived in this laboratory from a human mixed large cell and squamous carcinoma from an adult male, SK-MES-1, a cell line from human squamous carcinoma, was obtained from the ATCC (HTB-58), WIL, a cell line derived from human adenocar-cinoma was obtained from the Haddow Laboratories, Sutton, Surrey, NCI-H125, also from human adenocarcinoma, was obtained from Dr D.N. Carney, Mater Misericordiae Hospital, Dublin, and the human foetal lung fibroblast line, MOG-LF113, was isolated in this laboratory from a first trimester foetus and used between approximate generation numbers 15-35. All lines were maintained in a 1:1 mixture of Hams F1O:DMEM (NBL; Gibco) containing 2 mM glutamine (Gibco) and supplemented with foetal bovine serum (FBS; Biocon), the amount depending on the particular experiment. All the cell lines used were shown to be free of mycoplasma by monthly testing with the fluorescent DNA stain Hoescht 33258 (Chen, 1977 Measurement ofpulmonary surfactant Pulmonary surfactant (PS) was measured using a modification of the method of Smith (1977) . Briefly, at the end of each experimental procedure, A549 cells were labelled with 0.1ILCi ml-' (76 Ci mmol-) of [methyl-3H]-choline (Amersham) for 24 h at 37°C. The medium was removed and the cells washed three times with serum-free medium. PS was collected following incubation for 30 min with 3 ml of serumfree medium containing 1.0 mM isoprenaline (Sigma), and extracted in 9 ml of a 2:1 mixture of chloroform:methanol (BDH). The upper aqueous layer was removed and the lower layer dried in a vortex evaporator (Buchler). Disaturated phosphatidylcholine (DPPC) was purified by alumina column chromatography according to the method of Mason et al. (1976) . The samples were counted on a double channel scintillation counter. Recovery was calculated by incorporating a known amount of '4C-DPPC. Total cell-associated protein was measured using the Bradford protein assay (Bradford, 1976; BioRad) and the PS produced was expressed per mg of total protein.
In the direct co-culture experiments, a figure for the antici- quots from a 20 litre batch of conditioned medium were diluted 1:4 with equilibration buffer just prior to loading, and the diluted medium allowed to run under gravity at 4°C for 4 days. The flow rate was between 10 and 20 ml min-'. At the end of the run, proteins were eluted from the column using 1 M NaCl in 50 mM MES, pH 6.0. Fractions showing greatest surfactant inducing activity were pooled and precipitated out of solution with 60% (w/v) (NH4)2SO4, then lyophilised. This was designated FDF and was used in all subsequent assays, reconstituted in PBSA at 1.0 ltgml-'.
Plasminogen activator activity PA was assayed by a chromogenic assay using substrate S-2251 (KabiVitrum) and 0.15 mg ml ' poly-D-lysine (Whur et al., 1980) .
Cloning experiments
Monolayer Cells were trypsinised, and diluted to 100 cells ml-' in fresh culture medium, containing 10% FCS, and 5 ml aliquots seeded into 6 cm petri dishes (Nunclon), which were incubated for 10 days at 37°C to allow the formation of colonies. Colonies were fixed for 10 min in methanol (BDH), then air dried overnight, and stained with 0.1% crystal violet (BDH). Colonies greater than 0.5 mm (approx. 500 cells) were counted using an Artek colony counter.
Suspension A suspension of 103 cells ml1 in culture medium, supplemented with 10% FBS, and containing 0.3% agar (Gibco) was poured onto a preformed layer of 1% agar in 35 mm petri dishes (Nunclon). Thereafter, the cells were cultured for 14 days at 37°C in a humid 2% CO2 incubator.
Colonies were stained with 5 mg ml1l 3-[4,5-dimethylthiazoyl -2-yl]-2,5-diphenyl tetrazolium bromide (MTT; Sigma) for 4 h at 37°C in the dark. Colonies containing more than 20 cells were counted by eye using a binocular microscope.
Xenografts
Ten million A549 cells were injected into the flank of agematched MFI/NuNu/Ola/Hsd male nude mice, and allowed to grow to approximately 0.5 g. Statistical analysis was by unpaired student's t-test.
Results
Pulmonary surfactant production A549 cells were able to produce PS in culture, and this was enhanced by DX in a dose dependent manner (Figure la) reaching maximum stimulation at 0.1 ILg ml-' (0.25 gM).
Four other cell lines, L-DAN, MES-1, WIL and H125, were investigated to determine the specificity of the PS assay: PS synthesis appeared to be specific to A549, since, with the possible exception of L-DAN, none of the four other nonsmall cell lung carcinomas studied produced PS in any appreciable amounts (Table I ). The amount produced in L-DAN was not significantly different from the other lines. DX was cytostatic at high cell density, reducing the saturation density of A549 in a dose dependent manner (Figure lb) . This was confirmed in subsequent filter well cultures where A549 cell protein per filter was consistently lower in DX-treated cultures (data not shown).
A549 cells growing in filter wells produced 5-fold higher levels of PS in response to steroid, compared to only a 1.5-fold increase when the cells were cultured on a conventional plastic substrate (Table II) .
Effect offibroblasts A549 cells grown in filter wells responded to co-culture with LF-113, whether in direct co-culture or separated co-culture, by increasing the production of PS 5-fold (Table II) . Treat- aP<0.001 against DX-free control on filter; bP< 0.02 against DX-free control on filter, combined with fibroblasts; cP < 0.001 against fibroblast-free control without DX; dp <0.001 against fibroblast-free control with 0.25 laM DX; PJ<K 0.001I against fibroblast-conditioned medium without DEX pretreatment; *DX was removed 6 h before conditioning commenced (see text). ment of separated co-cultures with 0.25 ftM DX caused a further 4-fold increase in the production of PS, so that the total effect of fibroblasts plus steroid over the untreated filter a~w ell culture of A549 alone was a 20-fold increase in PS production. A549 cells growing in direct contact with LFl 13 fibroblasts did not show any increased activity in either fibroblastic or steroid induction of PS relative to separated co-culture. The fibroblast plus steroid effect was, if anything smaller. Data are corrected for the presence of fibroblast protein (see Materials and methods), but the precise contribution of fibroblastic protein in direct co-culture is not known.
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WiLI V.L. -JAM llJ, was UVctelrinIeIU onI tJt7 ceiis grlWn in filter wells. After 48 h incubation, FCM from untreated fibroblast gave higher levels of PS production than unconditioned medium, and this was increased further by pretreatment of the fibroblasts with DX (Table II) . These results confirmed that LF113 cells released a soluble factor(s) which could induce PS production in A549 cells, and that the production of this factor could be enhanced by DX. HPLC analysis of glucocorticoid treated LF1 13 cells showed a rapid fall in the glucocorticoid per cell and was undetectable ( < 5 ng/106 cells) 2 h after steroid removal (data not shown).
This suggests that glucocorticoid carry-over into conditioned medium is negligible. DX concentration [,uM] Partial purification of MOG-LFJ13 conditioned medium When ammonium sulphate precipitated fractions of FCM were assayed for stimulation of PS synthesis, the highest activity was observed in the 60% fraction (Figure 2a) . Fractionation of FCM on a Biorad preparative isoelectric focusing gradient apparatus gave highest activity in fraction 12, equivalent to pH 8.8 (Figure 2b ). Cation-exchange chromatography followed by precipitation with 60% ammonium sulphate were therefore chosen for steps in partial purification. Dialysed conditioned medium from glucocorticoid-treated fibroblasts was applied to S-Sepharose as described in the Materials and methods and eluted with 1.0 M NaCl. The first eight fractions, shown to contain the bulk of the activity (data not shown) were pooled and the protein precipitated with 60% (w/v) (NH4)2SO4. The resulting precipitate was designated FDF. A dose response curve for induction of PS with FDF is shown in Figure 3 , showing that maximum activity had still not been reached by 1 .tg ml-'. Figure 2 ) indicated a pK of 8.8. Heating to 56'C for 30 min or 100'C for 5 min destroyed about 20% of activity (Table III) . Acidification to pH 3.0 destroyed 90% of activity while increasing the pH to 9.0 had little effect. Digestion with 100 lg ml-' trypsin (Worthington, recrystallised) or 100 pg ml-' pronase (Sigma, S. griseus) removed 50% of the activity. This suggests that FDF is stable to heat and alkali but acid labile and protease sensitive (Table III) .
Physico-chemical characterisation Isoelectric focusing (see above and
Activity of other growth factors Eight other growth factors were assayed for surfactant induction at concentrations known to be active in other systems (Table IV) . Of these only PDGF, bFGF and IGF-I showed significant activity, but much less than FDF. Although FDF was present at 1.0 tg ml-' the bulk of this, as indicated by preliminary SDS-PAGE analysis, is probably inactive, contaminating, high molecular weight proteins. The apparent activity of insulin was not statistically significant, and subsequent assays with insulin at a range of concentrations from 0.1-10 igmlm' have not shown any stimulation (data not shown).
Phenotypic effects of FDF in vitro
Differentiation The data in Figure 3 indicate that FDF induces surfactant synthesis in A549 cells. This has been taken as evidence of differentiation. Growth and survival Monolayer cloning was performed on A549 cells which had been pre-treated with 0.1 ng ml-10 tig ml FDF for 3 days. FDF had no effect on the clonogenic potential of A549, with an average plating efficiency of 40% (approximately 200 colonies per petri dish) in both control and treated cultures. There was no difference in colony size between treated and controls (data not shown). A549 was able to grow well in semi-solid agar with a plating efficiency of around 33%. Pre-treatment of A549 cells in regular monolayer culture with FDF, 1.0pgml-1, caused a significant reduction in colony formation in agar by approximately 30%. Plasminogen activator (PA) PA activity was measured in both A549 and another human lung adenocarcinoma, WIL. Treatment of both cell lines with FDF caused a significant reduction in PA activity (Table V) .
Effect of FDF on growth of A549 cells as xenografts FDF significantly inhibited the growth of A549 as established xenografts (Figure 4 ) and histology revealed extensive structural reorganisation in the treated tumour ( Figure 5) , with stromal infiltration and signs of glandular-like or duct-like formation not evident in controls. Observation of the gross morphology of the tumours excised after treatment showed not only a significant difference in size but also a marked reduction in blood supply, judging by the whiter appearance of the tumour.
Discussion
This study examined the role of fibroblasts, and a fibroblastderived factor, on the differentiation of A549 type II pneumocyte tumour cells in vitro, and the effect of the factor on growth in vivo. PS synthesis and, particularly, the response to glucocorticoid, were greater when A549 cells were cultured on a filter well membrane rather than on a conventional plastic substrate, possibly due to the establishment of polarity and/or higher oxygen tension, being nearer to the gasliquid interface. In epithelial cells, the expression of complete differentiation requires the development of polarity within the cell (Sattler et al., 1978; Chambard et al., 1982) , although to what extent polarity is achievable in transformed cells is as yet unclear. It has been reported that for the correct expression of differentiated features in normal lung, it is often necessary to have the cells growing close to the air-liquid interface, since this mimics more closely the in vivo situation (Van Scott et al., 1986) , so elevating the culture closer to the surface of the medium may have contributed to increased PS synthesis.
The current data confirm that fibroblasts participate in the response of alveolar type II epithelial cells to hydrocortisone, and that the tumour cell line A549 retains this indirect response to steroid. A549 cells do respond to steroid directly, but to a much reduced extent. The addition of fibroblasts to the dish underlying the A549 cells in the filter increased the response of the A549 cells to DX nearly 4-fold over that of A549 alone. This effect was not increased by direct contact between the A549 cells and the fibroblasts, indicating that the major effect was due to a paracrine factor as previously described for normal developing lung (Smith, 1979) . This was confirmed by the activity of fibroblast-conditioned medium which stimulated production of surfactant in A549 cells, and the activity of which was also increased by glucocorticoid. The activity of the fibroblasts in the absence of DX suggests that they have constitutive synthesis and release a PS stimulating factor(s) which may be increased by DX or distinct from the DX induced effect. Other growth factors (PDGF, bFGF, and IGF-1) were shown to have some PS inducing ability and may be released by fibroblasts without steroid stimulation. Although fibroblast conditioned medium was shown to be active, a significant increase in this activity had been detected in medium conditioned by glucocorticoid-treated lung fibroblasts. A simple purification procedure was undertaken in an attempt to further enrich the activity of the conditioned medium, and reduce the risk of steroid carry-over. However, HPLC analysis indicated that steroid was undetectable (<5 ng/106 cells) by 2 h after steroid removal, and conditioning commenced at 6 h. As the cell concentration during conditioning was approximately 2.0 x I05cells ml-', the maximum possible concentration of steroid in conditioned medium would have been <1 ng ml' (2.5 x I0-9 M), previously found to be too low for induction of surfactant synthesis. In view of this and subsequent purification steps, it is unlikely that sufficient steroid remained to account for the activity of the partially purified FDF.
These experiments indicate the presence of a diffusible factor or factors, here called FDF, capable of stimulating PS production in A549 alveolar carcinoma cells. The activity of FDF was found to be heat and alkali stable but sensitive to acid and protease. From the review of the activities of other growth factors, the likeliest candidate would be PDGF. However, PDGF is stable in acid and is therefore unlikely to be the sole source of activity. Since bFGF and IGF-1 both showed some activity, it is possible, particularly in view of the heterogeneity of the material, that the total activity is due to a synergistic interaction of two or more already established growth factors. TGF-P was inactive and, in a recent report (Torday & Kourembanas, 1990) has been shown to antagonise the activity of FPF, the PS-inducing factor previously reported by Smith (1979) . Further purification and characterisation is clearly required before it can be established that this is a new and unique factor.
Initial results from Smith (1979) suggested that the activity described in normal developing lung was in a 5-7 Kd fraction and was acid stable. Material from the present purification was dialysed with a retention of approximately 10 Kd, and was found to be acid labile, and may therefore be distinct from Smith's FPF.
Proteolytic digestion with trypsin and pronase only reduced the activity by 50%. Since trypsin cleaves only on the carboxyl side of lysine and arginine residues, it may still have left active peptides, however, this is less likely with pronase, and it is therefore possible that digestion was incomplete, or some of the activity is not protein based.
The induction of surfactant synthesis in this system was shown to involve the formation of characteristic multilamellar bodies (data not shown) and is generally associated with terminal differentiation of type II pneumocytes. Increased clonogenicity in suspension (MacPherson & Montagnier, 1964) and elevated PA levels (Rifkind et al., 1974) have generally been associated with the malignant phenotype, although the expression of PA is by no means unique to tumour cells (Duffy & O'Grady, 1984; Camiolo & Greco, 1986) . The associated depression in suspension cloning and PA, together with the induction of PS synthesis, suggest that a general phenotypic change is occurring, with a coordinated shift away from malignancy towards differentiation. The possibility of such a relationship agrees with the findings of Frame et al. (1984) , who showed that in a panel of early passage glioma cell lines, less well differentiated cell lines expressed high PA levels, while a decrease in PA expression was observed in cells induced to differentiate with glucocorticoid and glia maturation factor.
FDF reduced clonogenicity in soft agar by about 30% without any effects in monolayer, suggesting specific inhibition of anchorage independent growth. This is in agreement with the observations of Shirasuna et al. (1988) , who noticed a marked reduction, not only in colony number, but also in colony size when a salivary adenocarcinoma cell line was treated with WI-38 conditioned medium.
As the factor represses tumour growth in vivo, this also substantiates the observation that induced differentiation represses malignancy. This may occur by increased sensitivity to density limitation of growth and the withdrawal of terminally differentiated cells from the proliferative pool. Furthermore, since the tumour seemed to be less well vascularised, induction of differentiation may have led to a reduction in angiogenesis factors produced by the tumours.
The inhibition of PA activity produced by the WIL cell line, derived from an adenocarcinoma, suggests that FDF activity may not be restricted to alveolar carcinoma, and preliminary data from treatment of other tumours in vivo, as yet with very small numbers of animals, suggests that FDF may have activity with other non-small cell lung cancers and small cell lung cancer, but not with ovarian carcinoma.
In summary these results provide good evidence that foetal lung stromal cells have important paracrine effects on malignant lung epithelium. This is due, at least in part, to a diffusible factor, which can be isolated, and the existence of which may point to a possible mode of antitumour therapy which should have minimal peripheral toxicity. Analogous activity has been observed in prostate where fibroblasts can influence the secretory capacity of prostatic carcinoma in a paracrine manner (Djaklew et al., 1990 ) and the appearance of columnar cells in prostatic carcinoma can be induced by genital tract mesoderm (Hayashi et al., 1990) , suggesting that this type of paracrine control may be widespread and potentially applicable to other types of carcinomas.
